Skip to content
MarketScale
‹ Back to Industries

Sciences

The Goals for Space Exploration for This Decade and Beyond

In this episode, Chris Blackerby and Charity Weeden speak with Ellen Stofan, Under Secretary of Science and Research at the Smithsonian, about the trajectory of space exploration in the current decade and beyond. The conversation covers the evolving roles of government agencies and private sector companies, as well as the importance of public engagement in advancing space science. Stofan draws on her extensive career at NASA and the Smithsonian to outline priorities and challenges facing the space community.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Chris Blackerby · International Space StationSpaceSustainabilityThe Expanse
Share

Key takeaways

01

Government and private sector collaboration is central to advancing space exploration goals this decade.

02

Public engagement and science communication are critical to sustaining support for space missions.

03

Ellen Stofan highlights the evolving priorities at NASA and the Smithsonian in shaping the future of space science.

The expanse of space, the wondrous and eerie world that very few individuals have experienced. In this episode, Chris Blackerby and Charity Weeden talk to Ellen Stofan, Under Secretary of Science and Research at the Smithsonian, about the future of space exploration in the government and private sectors, the public.

Stofan’s career in space was destined when she was four years old and watched a launch of the ATLAS-CENTAUR. Her father was an engineer on the rocket. However, the rocket exploded, and the vast mushroom cloud made four-year-old-Stofan remember the moment forever. The explosion was an unfortunate outcome, and it’s important to remember that a test flight that produces knowledge is not a failure.

She said that launches are one of her favorite parts of her job, but to this day, she gets nervous. “It’s an overwhelming feeling when the hardware you worked on is out in space,” chimed in the host, Blackerby. “When we launched our first satellite in March of last year, [it] was so emotional.”

Stofan became interested in geology and soon realized that geology and space go hand in hand. Stofan became Chief Scientist at Nasa, where her focus was getting Nasa Data into the hands of people worldwide to help combat climate change.

Today, Stofan believes that this decade will be vital in determining the future of space exploration. As private investments into the expanse become the norm, the government will be able to shift its focus to further investigation, like Mars. Determining and applying something like the Leeds Standards [sustainability-focused practices in the building industry] to space building and exploration is necessary to establishing space sustainability. Sustainability will be required, from how space crafts are disposed of to entering and exiting orbit. Since space is a global common, authority is undetermined. The public will play a vital role in ensuring that sustainable practices happen immediately.

More in This Series

About the author

CB
Chris Blackerby

New to MarketScale?

MarketScale is the platform Sciences companies use to turn their own experts into content like this. Want the short overview?

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I clinical study of an oral solid dose formulation designed using AI, cleared by the UK's MHRA and conducted at the company's UK facility. The trial—built on machine learning algorithms from partner Intrepid Labs and Quotient's Translational Pharmaceutics platform—aims to validate AI as a direct contributor to formulation design rather than just an upstream analytical tool. Benchling characterizes the broader moment as biotech entering a "builder phase," in which leading organizations embed AI capability at the bench level rather than running isolated pilots.

  • 01Quotient Sciences has dosed healthy volunteers in a Phase I study it describes as the first clinical evaluation of an AI-designed oral formulation, following approval from the UK's MHRA.
  • 02The formulation was developed using advanced machine learning algorithms from Intrepid Labs, integrated with Quotient Sciences' Translational Pharmaceutics platform.
  • 03Benchling identifies a sector-wide shift toward embedding AI capability directly at the bench, moving beyond isolated pilots to structural adoption across biotech R&D.

Jun 17, 2026

Tekniplex Showcases Sustainable Materials Innovation at Paris Packaging Week 2026

Tekniplex Showcases Sustainable Materials Innovation at Paris Packaging Week 2026

At Paris Packaging Week 2026, Tekniplex showcased its latest sustainable materials innovations, emphasizing the intersection of materials science and brand storytelling. The company's booth featured a living wall and digital displays to engage a sustainability-conscious audience, highlighting advanced materials for sustainability and product performance in cosmetics packaging.

  • 01Tekniplex emphasized sustainable materials innovation at Paris Packaging Week 2026.
  • 02The company's booth featured eco-friendly design elements and immersive digital displays.
  • 03Tekniplex highlighted advancements in recyclable sealing systems and materials for cosmetics.

Apr 9, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Experts

CB
Chris Blackerby

Partner, Government & Public Sector at EY

Chris Blackerby is a partner at EY focused on aerospace and government sectors, with a background spanning NASA and international space policy. He has held leadership roles including COO of the Asia-Pacific region for NASA and has worked on commercial space initiatives. Blackerby is a recognized voice on the intersection of government, private industry, and space exploration.

ES
Ellen Stofan

Under Secretary of Science and Research

Smithsonian Institution

Ellen Stofan is the Under Secretary of Science and Research at the Smithsonian Institution, overseeing its science research and museum units. She previously served as NASA's Chief Scientist from 2013 to 2016 and has had a distinguished career in planetary science. Stofan is a leading advocate for human and robotic space exploration.

CW
Charity Weeden

Vice President, Global Space Policy

Astroscale

Charity Weeden is a space policy expert with extensive experience in government and industry roles related to commercial space and satellite operations. She has held senior positions focused on space policy and regulatory affairs. Weeden is a frequent speaker on issues of space sustainability and international space governance.